References
- O’BrienCSchwartzBTakamotoTWuDCIntraocular pressure and the rate of visual field loss in chronic open-angle glaucomaAm J Ophthalmol199111144915002012152
- CairnsJETrabeculectomy. Preliminary report of a new methodAm J Ophthalmol19686646736794891876
- ReddickRMerrittJCRossGAveryAPeifferRLMyofibroblasts in filtration operationsAnn Ophthalmol19851732002033994223
- MostafaeiAAugmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trialClin Ophthalmol2011549149421573097
- GreenfieldDSSuñerIJMillerMPKangasTAPalmbergPFFlynnHWJrEndophthalmitis after filtering surgery with mitomycinArch Ophthalmol199611489439498694729
- SeahSKPrataJAJrMincklerDSBaerveldtGLeePPHeuerDKHypotony following trabeculectomyJ Glaucoma199542737919920649
- BaoPKodraATomic-CanicMGolinkoMSEhrlichHPBremHThe role of vascular endothelial growth factor in wound healingJ Surg Res2009153234735819027922
- NissenNNPolveriniPJKochAEVolinMVGamelliRLDiPietroLAVascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healingAm J Pathol19981526144514529626049
- Lopilly ParkHYKimJHAhnMDParkCKLevel of vascular endothelial growth factor in tenon tissue and results of glaucoma surgeryArch Ophthalmol2012130668568922332204
- TripathiRCLiJTripathiBJChalamKVAdamisAPIncreased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucomaOphthalmology199810522322379479280
- HuDNRitchRLiebmannJLiuYChengBHuMSVascular endothelial growth factor is increased in aqueous humor of glaucomatous eyesJ Glaucoma200211540641012362079
- MiyakeTSawadaOKakinokiMPharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyesInvest Ophthalmol Vis Sci20105131606160819875666
- KahookMYSchumanJSNoeckerRJIntravitreal bevacizumab in a patient with neovascular glaucomaOphthalmic Surg Lasers Imaging200637214414616583637
- GrewalDSJainRKumarHGrewalSPEvaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot studyOphthalmology2008115122141. e22145. e218692246
- NilforushanNYadgariMKishSKNassiriNSubconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomyAm J Ophthalmol20121532352. e1357. e121982106
- HowAChuaJLCharltonACombined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgeryInvest Ophthalmol Vis Sci201051292893219797222
- MemarzadehFVarmaRLinLTPostoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbitInvest Ophthalmol Vis Sci20095073233323719182254
- KlinkTSchreySElsesserUKlinkJSchlunckGGrehnFInterobserver variability of the Wurzburg bleb classification scoreOphthalmologica2008222640841318849624
- KlinkTKannGEllingerPKlinkJGrehnFGuthoffRThe prognostic value of the Wuerzburg bleb classification score for the outcome of trabeculectomyOphthalmologica20112251556020714183
- EssonDWPoppMPLiuLSchultzGSSherwoodMBMicroarray analysis of the failure of filtering blebs in a rat model of glaucoma filtering surgeryInvest Ophthalmol Vis Sci200445124450446215557454
- LiZVan BergenTVan de VeireSInhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgeryInvest Ophthalmol Vis Sci200950115217522519474408
- MathewRBartonKAnti-vascular endothelial growth factor therapy in glaucoma filtration surgeryAm J Ophthalmol2011152110. e215. e221620367
- O’NeillECQinQVan BergenNJAntifibrotic activity of bevacizumab on human Tenon’s fibroblasts in vitroInvest Ophthalmol Vis Sci201051126524653220574016
- NomotoHShiragaFKunoNPharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbitsInvest Ophthalmol Vis Sci200950104807481319324856